Franklin Lakes, NJ-BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it has signed an agreement to acquire GeneOhm Sciences, Inc., a privately held company headquartered in San Diego, California that has pioneered the development of molecular diagnostic testing for the rapid detection of bacterial organisms, including those known to cause healthcare-associated infections (HAIs). GeneOhm […]
CARLSBAD, Calif.,– Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced that its subsidiary, Invitrogen Federal Systems, was awarded a $970K Technical Assistance Agreement by the U.S. Department of Defense to produce and validate protein microarrays to biothreat agents. This work will be conducted under the […]
Venlo , The Netherlands and Hamburg , Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) and Eppendorf AG today announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimized products. The alliance is intended to link two of the strongest brands and product lines in […]
Foster City, CA and Austin, TX —Applied Biosystems has signed a definitive agreement to acquire Ambion’s Research Products Division, a supplier of RNA-based reagents, for $273 million in cash. Ambion’s Research Products Division sells sample preparation, RNAi, micro RNA, and gene expression and array products. Ambion’s 2005 revenues are forecasted to increase 22% to more […]
Foster City, CA and Austin, TX —Applied Biosystems has signed a definitive agreement to acquire Ambion’s Research Products Division, a supplier of RNA-based reagents, for $273 million in cash. Ambion’s Research Products Division sells sample preparation, RNAi, micro RNA, and gene expression and array products. Ambion’s 2005 revenues are forecasted to increase 22% to more […]
Seattle, WA and Carlsbad, CA- Invitrogen has agreed to acquire Xcyte Therapies’ cell expansion technology, including intellectual property, clinical data, raw materials and equipment, for $5 million in cash. In addition, Xcyte will also be entitled to a percentage of sublicensing revenue related to the intellectual property for therapeutic applications. “To Invitrogen, this transaction represents […]
Venlo , The Netherlands and Foster City , CA – – QIAGEN N.V.Frankfurt , Prime Standard: QIA) and Applied Biosystems Group an Applera Corporation business announced that they have entered into a license agreement. Under the terms of the agreement, Applied Biosystems has granted a license to QIAGEN under the expanded Applied Biosystems PCR (polymerase […]
Gothenburg, Sweden: Cellectricon today announced the launch of the new Dynaflow (TM) Pro II System for safety pharmacology studies. The system comes with the newly developed DF-8 Pro II Chip successfully beta-tested for conducting GLP hERG studies by Swiss ion channel CRO bSys GmbH. Developed for life scientists and drug discovery researchers, the Dynaflow System […]
WASHINGTON, DC – Today at the Society of Neuroscience meeting in Washington, D.C., GE Healthcare launched Ad-A-Gene Vectors, a large range of ready-to-use, validated adenoviral vector gene delivery reagents. The reagents expand the possibilities for lead compound profiling, drug target validation and basic research by enabling the rapid development of transient cell signaling assays. The […]
Platform Enables Researchers to Profile All Known miRNAs from Humans Plus Additional Human Predicted miRNAs and Most Studied Genomes CARLSBAD, Calif.–Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company with a broad portfolio of technologies to improve and accelerate biomedical research, drug discovery and commercial bioproduction, today introduced its NCode(TM) microRNA (miRNA) Microarray platform. The NCode(TM) […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
